Fajardo TYL, Nápoles MJD, Álvarez AA, Millares RA, Ocaña COM

Language: Spanish
References: 16
Page: 1-13
PDF size: 322.79 Kb.

ABSTRACT

Introduction: Hypertensive alterations that accompany pregnancy determine frequent obstetric complications and notable maternal and perinatal morbidity and mortality. It is an entity of sustained prevalence, despite the great efforts to control it and the search for preventive measures.
Objectives: To determine the prevalence of chronic arterial hypertension in patients with history of preeclampsia and to characterize the sample.
Methods: A cross-sectional observational study was carried out of patients treated in the maternity ward at Carlos Manuel de Céspedes University Hospital in Bayamo, Granma, Cuba, from March 1, 2017 to February 29, 2020. One hundred sixty-two patients were assessed. They suffered pre-eclampsia and attended the hypertension clinic 12 weeks after delivery to determine whether or not hypertension persisted, which would classify them as chronic hypertensive. Data collection was performed only once in this consultation and descriptive statistics were used for information processing.
Results: The prevalence of chronic arterial hypertension after preeclampsia was 27.7%. the age range between 20 and 35 years predominated in 62.22%. Most of the patients had no relevant genetic history. Obesity had high percentage in the sample (24.44%). 62.22% of the sample was controlled with a single hypotensive. Only 13.33% of the patients had preeclampsia with proven multi-organ damage.
Conclusions: The prevalence of chronic arterial hypertension after preeclampsia is high and the non-aggravated form of preeclampsia predominates as the antecedent.

REFERENCES

1. Sibai BM. Etiology and management of postpartum hypertension-preeclampsia. Am J Obstet Gyneco. 2012;206(6):470-5. DOI: http://doi.org/c3ft89.

2. Sibai BM. Management of late preterm and early-term pregnancies complicated by mild gestational hypertension/pre-eclampsia. Seminars in Perinatology. 2011;35(5):292–6. DOI: http://doi.org/10.1053/j.semperi.2011.05.010.

3. Schutte JM, Schuitemaker NW, Van Roosmalen J, Steegers EA. Dutch Maternal Mortality Committee Substandard care in maternal mortality due to hypertensive disease in pregnancy in the Netherlands. BJOG: An International Journal of Obstetrics and Gynaecology. 2008;115(6):732–6. DOI: http://doi.org/10.1111/j.1471-0528.2008.01702.x.

4. Informe de estadística de la maternidad del Hospital Provincial Universitario Carlos Manuel de Céspedes y del Castillo. Bayamo, Cuba: 2019.

5. American College of Obstetricians and Gynecologists and Task Force on Hypertension in Pregnancy. Hypertension in pregnancy. Report of the American college of obstetricians and gynecologists’ task force on hypertension in pregnancy. Obstetrics & Gynecology. 2013;122(5):1122–31. DOI: http://doi.org/10.1097/01.aog.0000437382.03963.88.

6. Pettit F, Mangos G, Davis G, Henry A, Brown MA. Pre-eclampsia causes adverse maternal outcomes across the gestational spectrum. Pregnancy Hypertension: An International Journal of Women’s Cardiovascular Health. 2015;5(2):198–204. DOI: http://doi.org/10.1016/j.preghy.2015.02.002.

7. Li XL, Guo PL, Xue Y, Gou WL, Tong M, Chen Q. An analysis of the differences between early and late preeclampsia with severe hypertension. Pregnancy Hypertension: An International Journal of Women’s Cardiovascular Health. 2016;6(1):47–52. DOI: http://doi.org/10.1016/j.preghy.2015.12.003.

8. Bokslag A, van Weissenbruch M, Mol BW, de Groot CJ. Preeclampsia; short and long-term consequences for mother and neonate. Early Human Development. 2016;102:47–50. DOI: http://doi.org/10.1016/j.earlhumdev.2016.09.007.

9. Brown MA, Magee LA, Kenny LC, Karumanchi SA, McCarthy FP, Saito S. The hypertensive disorders of pregnancy: ISSHP classification, diagnosis & management recommendations for international practice. Pregnancy Hypertension: International Journal of Women’s Cardiovascular Health. 2018. DOI: http://doi.org/10.1002/uog.19085.

10. Pinheiro TV, Brunetto S, Ramos JG, Bernardi JR, Goldani MZ. Hypertensive disorders during pregnancy and health outcomes in the offspring: A systematic review. Journal of Developmental Origins of Health and Disease. 2016;7(4):391–407. DOI: http://doi.org/10.1017/S2040174416000209.

11. Rolnik DL, Wright D, Poon LC, et al. Aspirin versus Placebo in Pregnancies at High Risk for Preterm Preeclampsia. The New England Journal of Medicine. 2017;377(7):613–22. DOI: http://doi.org/10.1056/NEJMoa1704559.

12. Kalafat E, Sukur YE, Abdi A, Thilaganathan B, Khalil A. Metformin for prevention of hypertensive disorders of pregnancy in women with gestational diabetes or obesity: systematic review and meta-analysis of randomized trials. Ultrasound in Obstetrics & Gynecology. 2018 DOI: http://doi.org/10.1002/uog.19084.

13. Girardi G. Pravastatin to treat and prevent preeclampsia. Preclinical and clinical studies. Journal of Reproductive Immunology. 2017;124:15–20. DOI: http://doi.org/10.1016/j.jri.2017.09.009.

14. Costantine MM, Cleary K, Hebert MF. Safety and pharmacokinetics of pravastatin used for the prevention of preeclampsia in high-risk pregnant women: A pilot randomized controlled trial. American Journal of Obstetrics & Gynecology. 2016;214(6):720. e1–720.e17. DOI: http://doi.org/10.1016/j.ajog.2015.12.038. [PMC free article]

15. Tayyar A, Krithinakis K, Wright A, Wright D, Nicolaides KH. Mean arterial pressure at 12, 22, 32 and 36 weeks' gestation in screening for pre-eclampsia. Ultrasound in Obstetrics & Gynecology. 2016;47(5):573–9. DOI: http://doi.org/10.1002/uog.15815. 16. Alonso Cedeño B. Hipertensión Postparto: una revisión de la literatura y los protocolos de manejo. Rev Fac Med 2015;62(3):251¬8. DOI: http://doi.org/10.15446/revfacmed.v63n2.48001.

16. Visintin C, Mugglestone MA, Almerie MQ, Nherera LM, James D, Walkinshaw S. Management of hypertensive disorders during pregnancy: summary of NICE guidance. British Medical Journal. 2010;341(5):192-9. DOI: http://doi.org/10.1136/bmj.c2207.c2207